Clin2
NCT03575000Possibly a fitNot yet recruiting

Bromocriptine for prediabetes in schizophrenia

SchizophreniaPreDiabetes

Part of Hormones & metabolism, Mental health clinical trials.

This study tests whether bromocriptine, a medication that may improve blood sugar control, can help people with schizophrenia who have prediabetes. If you qualify, you might receive the drug or a placebo to see if it helps prevent diabetes.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
15 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are between 18 and 65 years old and have a diagnosis of schizophrenia.
  • You have been taking a second-generation antipsychotic medication for at least 3 months, with no dose change in the last month.
  • You have prediabetes, shown by a fasting blood sugar between 100 and 125 mg/dL or an A1C between 5.7% and 6.4%.
  • Your body mass index (BMI) is 30 or higher.
  • You are not currently taking any diabetes medications (like metformin or insulin) and have not taken them in the past 4 months.
  • You are willing to provide contact information for a family member or friend who can reach the study team if you show signs of getting worse.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07558525Not yet recruiting
Studying a new medication to reverse prediabetes

This study tests whether a new medication called chiglitazar sodium, combined with a lifestyle program, can help reverse prediabetes (when blood sugar is high but not yet diabetes). It could help you lower your blood sugar and reduce your risk of developing type 2 diabetes.

Quanzhou, Fujian
NCT05951660Recruiting
Study sexual side effects in schizophrenia with diabetes

This study looks at how sexual functioning is affected in people with schizophrenia, especially in those who also have diabetes or weight-related risk. It also examines how psychiatric medicines and diabetes/weight factors may be connected, which could help improve care for patients.

Slagelse
NCT07045142Recruiting· Phase 3
Metformin for blood sugar issues from statins in schizophrenia

This trial tests whether metformin can help prevent or manage blood sugar problems that may arise when people with schizophrenia take statins (cholesterol-lowering drugs). If you have schizophrenia, are on a stable medication routine, and have high cholesterol but not diabetes, this study might be an option.

Zhumadian, Henan
NCT06468553Recruiting
Support program for prediabetes to prevent diabetes

This study tests a team-based program (doctors, dietitians, psychologists) to help people with prediabetes improve their blood sugar, weight, and quality of life through healthy eating and exercise. It may be a good fit if you want support to prevent diabetes.

Mexico City, Iztapalapa
NCT07326891Recruiting
Mediterranean diet with cycling and rowing for blood sugar in prediabetic women

This trial tests whether following a Mediterranean diet and doing cycling and rowing exercise can help lower blood sugar in women with prediabetes. It may help you find a safe way to prevent or delay diabetes.

Beykoz, Istanbul
NCT07392151Not yet recruiting· Phase 3
Reversing prediabetes to normal blood sugar

This study tests whether a medication can bring blood sugar back to normal in people with heart disease who have prediabetes (higher-than-normal blood sugar). It might help prevent diabetes and improve heart health.

Aarhus N

Hear when a new Schizophrenia trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.